Clinical trial shows the effectiveness of electrical stimulation on women with constipation

NewsGuard 100/100 Score

Electrical stimulation benefited women with constipation in a recent clinical trial published in Alimentary Pharmacology & Therapeutics.

In the trial, 33 women with constipation that had not improved with standard treatment received either real or sham electrical stimulation on the stomach and back for 1 hour each day for 6 weeks. The women did not know whether they were receiving the real or the sham treatment.

Treatment was successful in 53% of the women in the first group but only 12% in the second. Furthermore, the improvement in symptoms lasted for at least 3 months after the treatment ended, and there were no reported side effects.

This treatment is very promising and offers patients a well-tolerated alternative to laxative medications."

Judith S. Moore, PhD, RN, Study Lead Author, Monash University in Australia

Source:
Journal reference:

Moore, J. S. et al. (2020) Randomised clinical trial: transabdominal interferential electrical stimulation vs sham stimulation in women with functional constipation. Alimentary Pharmacology & Therapeutics. doi.org/10.1111/apt.15642.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Revvity Signals Software unveils Signals Clinical solution to accelerate critical clinical trial insights and data-driven decisions